211 related articles for article (PubMed ID: 10656226)
21. HLA alleles and IDDM in children in Hungary: a comparison with Finland.
Hermann R; Mijovic CH; Rayner M; Croft N; Kelly MA; Jenkins D; Soltész G; Barnett AH
Hum Immunol; 2001 Apr; 62(4):391-8. PubMed ID: 11295472
[TBL] [Abstract][Full Text] [Related]
22. Estimation of genetic risk for type 1 diabetes.
Ilonen J; Sjöroos M; Knip M; Veijola R; Simell O; Akerblom HK; Paschou P; Bozas E; Havarani B; Malamitsi-Puchner A; Thymelli J; Vazeou A; Bartsocas CS
Am J Med Genet; 2002 May; 115(1):30-6. PubMed ID: 12116174
[TBL] [Abstract][Full Text] [Related]
23. The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns.
Mikk ML; Heikkinen T; El-Amir MI; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Toppari J; Knip M; Ilonen J;
HLA; 2017 Apr; 89(4):215-224. PubMed ID: 28185422
[TBL] [Abstract][Full Text] [Related]
24. HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus.
Chuang LM; Wu HP; Chang CC; Tsai WY; Chang HM; Tai TY; Lin BJ
Clin Endocrinol (Oxf); 1996 Nov; 45(5):631-6. PubMed ID: 8977762
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of Type I diabetes.
Ionescu-Tîrgoviste C; Guja C; Herr M; Cucca E; Welsh K; Bunce M; Marshall S; Todd JA
Diabetologia; 2001 Oct; 44 Suppl 3():B60-6. PubMed ID: 11724419
[TBL] [Abstract][Full Text] [Related]
26. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR and -DQ polymorphism in Cameroon.
Pimtanothai N; Hurley CK; Leke R; Klitz W; Johnson AH
Tissue Antigens; 2001 Jul; 58(1):1-8. PubMed ID: 11580849
[TBL] [Abstract][Full Text] [Related]
28. DR- and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*.
Redondo MJ; Kawasaki E; Mulgrew CL; Noble JA; Erlich HA; Freed BM; Lie BA; Thorsby E; Eisenbarth GS; Undlien DE; Ronningen KS
J Clin Endocrinol Metab; 2000 Oct; 85(10):3793-7. PubMed ID: 11061540
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility alleles at HLA-DRB1, -DQA1, and -DQB1 loci in Ethiopian childhood insulin-dependent diabetes mellitus.
Abdulkadir J; Worku Y; Giphart MJ; Telahun M; Roep BO; Ottenhoff TH; Schreuder GM
Hum Immunol; 1994 Oct; 41(2):171-2. PubMed ID: 7860364
[No Abstract] [Full Text] [Related]
30. Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM.
Tosi G; Facchin A; Pinelli L; Accolla RS
Diabetes Care; 1994 Sep; 17(9):1045-9. PubMed ID: 7988304
[TBL] [Abstract][Full Text] [Related]
31. HLA class II typing of whole genome amplified mouth swab DNA.
Gillespie KM; Valovin SJ; Saunby J; Hunter KM; Savage DA; Middleton D; Todd JA; Bingley PJ; Gale EA
Tissue Antigens; 2000 Dec; 56(6):530-8. PubMed ID: 11169243
[TBL] [Abstract][Full Text] [Related]
32. HLA class II DRB1, DQA1 and DQB1 polymorphisms in the Polish population from Wielkopolska.
Jungerman M; Sanchez-Mazas A; Fichna P; Ivanova R; Charron D; Hors J; Djoulah S
Tissue Antigens; 1997 Jun; 49(6):624-8. PubMed ID: 9234484
[TBL] [Abstract][Full Text] [Related]
33. HLA-DQ and TAP2 genes in patients with insulin-dependent diabetes mellitus.
Lotfi M; Sastry A; Ye M; VanderMeulen J; Dosch HM; Singal DP
Immunol Lett; 1994 Jul; 41(2-3):201-4. PubMed ID: 8002038
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of HLA-DRB1, -DQA1 and -DQB1 polymorphism in Turkey.
Saruhan-Direskeneli G; Uyar FA; Bakar S; Eraksoy M
Tissue Antigens; 2000 Feb; 55(2):171-4. PubMed ID: 10746791
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of HLA DRB1, DQA1 and DQB1 alleles and susceptibility to IDDM in Chilean subjects. Chile IDDM Study Group.
Perez-Bravo F; Serrano-Rios M; Gutierrez-Lopez MD; Calvillan M; Garcia de los Rios M; Kocova M; Dorman J; Trucco M
Diabetologia; 1995 Mar; 38(3):378-9. PubMed ID: 7758887
[No Abstract] [Full Text] [Related]
36. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302.
Nejentsev S; Reijonen H; Adojaan B; Kovalchuk L; Sochnevs A; Schwartz EI; Akerblom HK; Ilonen J
Diabetes; 1997 Nov; 46(11):1888-92. PubMed ID: 9356041
[TBL] [Abstract][Full Text] [Related]
37. The HLA-B*39 allele increases type 1 diabetes risk conferred by HLA-DRB1*04:04-DQB1*03:02 and HLA-DRB1*08-DQB1*04 class II haplotypes.
Mikk ML; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Simell O; Knip M; Ilonen J;
Hum Immunol; 2014 Jan; 75(1):65-70. PubMed ID: 24055898
[TBL] [Abstract][Full Text] [Related]
38. HLA-DRB1, DQA1, DQB1 DNA polymorphism in the Bulgarian population.
Ivanova R; Naoumova E; Lepage V; Djoulah S; Yordanov Y; Loste MN; Charron D
Tissue Antigens; 1996 Feb; 47(2):122-6. PubMed ID: 8851725
[TBL] [Abstract][Full Text] [Related]
39. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group.
Ilonen J; Reijonen H; Herva E; Sjöroos M; Iitiä A; Lövgren T; Veijola R; Knip M; Akerblom HK
Diabetes Care; 1996 Aug; 19(8):795-800. PubMed ID: 8842593
[TBL] [Abstract][Full Text] [Related]
40. HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients.
Agardh E; Gaur LK; Lernmark A; Agardh CD
J Diabetes Complications; 2004; 18(1):32-6. PubMed ID: 15019597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
